Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · OCTAVE SPECIALTY GROUP INC (OSG)

Octave Specialty Group Q2 revenue rises 51% to $83.0 million; net loss narrows

Positive Impact 3 of 5 earnings Written later

Octave Specialty Group reported second-quarter 2026 revenue of $83.0 million, up 51% from $55.0 million a year earlier, led by its Insurance Distribution segment and the ArmadaCare acquisition. Net loss attributable to shareholders was $14.4 million, or $(0.33) per diluted share, compared with a $72.7 million loss a year earlier that included discontinued operations. The company will discuss its results and updated 2026 guidance on a call on August 7, 2026.

Key points

  • Total revenue of $83.0 million for Q2 2026, up 51%; Insurance Distribution revenue rose 77% to $58.4 million with 44.1% organic growth
  • Net loss attributable to shareholders of $14.4 million, or $(0.33) per diluted share, versus $72.7 million, or $(1.51) per share, in Q2 2025
  • Adjusted EBITDA to shareholders was $3.7 million versus $(4.6) million a year earlier; Everspan combined ratio improved to 100.6% from 106.7%

The filing

CompanyOCTAVE SPECIALTY GROUP INC (OSG)
Form8-K, current report
Filed with the SECAug 6, 2026, 4:58 PM ET
Accession number0001628280-26-054440

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.